Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
ICLL completed its previously announced acquisition of the 54% of Pelias it did not own for about 350,000 shares (see BioCentury, Dec. 11, 2006). The shares are valued at E6.4 million ($8.4 million) b...